Journal article
ApoB in clinical care: Pro and Con
Atherosclerosis, Vol.282, pp.169-175
03/2019
DOI: 10.1016/j.atherosclerosis.2018.11.001
PMID: 30463677
Abstract
Whether apoB adds significantly to the assessment of the risk and therapy of the atherogenic dyslipoproteinemias has been vigorously contested over many years. That trapping of apoB lipoprotein particles within the arterial wall is fundamental to the initiation and maturation of atherosclerotic lesions within the arterial wall is now widely accepted. At the same time, the concept that primary prevention should be based on the risk of a cardiovascular event, a measure that integrates the effects of age, sex, blood pressure, lipids and other factors, has also become widely accepted. Within the risk framework, the issue becomes whether apoB adds significantly to the assessment of risk. On the other hand, it can be argued that the risk model undervalues how important a role that LDL and blood pressure play as causes of atherosclerosis and that when considered as causes, the importance of apoB emerges. These are the two sides of the debate that will be presented in the article that follows: one will highlight the pros of measuring apoB, the second the cons. The reader can make up his or her mind which side of the issue they favour.
Highlights - Pro•ApoB is a more accurate measure of cardiovascular risk than LDL C or non HDL C.•ApoB is a more accurate measure of the adequacy of lipid therapy than LDLC or non HDL C.•ApoB is essential to diagnose Type III hyperlipidemia.•ApoB should replace LDL C/non-HDL C in routine clinical care.Highlights – Con•Apo B lipoprotein measurement needed for research.•Apo B levels - Too much information for clinic.•Apo B - Not needed for risk prediction in primary prevention.•Apo B - Not needed for determining treatment thresholds/goals.•Apo B - Not needed for guiding treatment.
Details
- Title: Subtitle
- ApoB in clinical care: Pro and Con
- Creators
- Allan D Sniderman - McGill University Health Centre, Royal Victoria Hospital, 1001 Decarie Boulevard, Montreal, Quebec, H4A 3J1, CanadaJennifer G Robinson - Departments of Epidemiology and Internal Medicine, Division of Cardiology, University of Iowa, 145 N Riverside Dr S455 CPHB, Iowa City, IA, 52242, United States
- Resource Type
- Journal article
- Publication Details
- Atherosclerosis, Vol.282, pp.169-175
- Publisher
- Elsevier B.V
- DOI
- 10.1016/j.atherosclerosis.2018.11.001
- PMID
- 30463677
- ISSN
- 0021-9150
- eISSN
- 1879-1484
- Language
- English
- Date published
- 03/2019
- Academic Unit
- Epidemiology; Internal Medicine
- Record Identifier
- 9983995129902771
Metrics
30 Record Views